Dublin, July 04, 2025 (GLOBE NEWSWIRE) — The “North America Beta-Glucan Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been added to ResearchAndMarkets.com’s offering.
The North America Beta Glucan Market was valued at USD 204.03 million in 2024 and is expected to grow to USD 373.85 million by 2033, growing at a CAGR of 6.96% from 2025 to 2033. The growth is due to increasing consumer demand for immune-boosting ingredients, enhanced application in functional foods and dietary supplements, and rising awareness of the health benefits of beta glucan throughout the region.
With an increased emphasis on preventive health and clean-label ingredients, North American consumers are increasingly looking for products containing beta glucan. The ingredient’s established health benefits combined with high demand for natural and plant-based additives continue to drive its traction across mainstream as well as niche health product categories.
Growth Driver in the North America Beta Glucan Market
Increased Demand for Functional Foods
The increased demand for functional foods by North American consumers is largely fueling the beta glucan market. As consumers take more interest in their health, they are increasingly looking for food products providing extra benefits other than plain nutrition. Beta glucan, with its properties of lowering cholesterol and improving immunity, is a perfect fit for this demand. Manufacturers are incorporating it into cereals, beverages, and snack bars, driving demand throughout the region.
Growing Nutraceuticals Industry
The fast growth of the nutraceuticals industry in North America is another key driver for beta glucan. As consumers opt for dietary supplements for immunity and heart health, beta glucan is being widely used for its proven bioactive properties. Incorporation in tablets, powders, and health drinks has opened up market opportunities, particularly as the aging population looks for preventative health products.
Feb 2025, Layn Natural Ingredients has opened a more extensive biotechnology plant to specialize in precision fermentation and enzyme-based technology. This plant will maximize large-scale production of eco-friendly bioactive ingredients, further increasing Layn’s efficiency and sustainability in manufacturing pure ingredients.
More Research and Clinical Validation
Continuing clinical studies and increased scientific endorsement of the benefits of beta glucan are driving market expansion. Research affirming its effectiveness in reducing cholesterol, stimulating immune function, and regulating blood sugar is adding to its credibility and usage by health professionals and consumers alike. This expanding body of evidence has spawned regulatory endorsement and wider use in food and pharmaceutical applications. June 2024: Cargill’s barley beta-glucan concentrate will gain new health claim approval from the U.S. Food and Drug Administration (FDA), associating the ingredient with a lower risk of heart disease.
Challenges in the North America Beta Glucan Market
High Production and Extraction Costs
One of the primary issues in the North America beta glucan market is the production and extraction cost. The extraction of beta glucan from oats, barley, or mushrooms is a capital-intensive process that demands advanced machinery and technology, thus elevating the overall production cost of the final product. This makes it difficult to use it in price-sensitive markets and confines small-scale companies from joining the industry.
Limited Consumer Awareness
Though it has advantages, beta glucan is still not well-known among mainstream consumers in North America. It is still not well understood by many regarding its sources and possible health impacts, which can limit demand. Without proper awareness campaigns and education programs, the market’s growth potential is not being fully utilized, particularly among mainstream food consumers who are not knowledgeable about functional ingredients.
Key Players Analysis: Overviews, Key Persons, Recent Developments, Revenue
- Koninklijke Philips N.V.
- EDAP TMS S.A
- Johnson & Johnson
- Medtronic Plc.
- Hitachi Ltd.
- Theraclion
- Stryker
- General Electrics
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2024 – 2033 |
| Estimated Market Value (USD) in 2024 | $204.03 Million |
| Forecasted Market Value (USD) by 2033 | $373.85 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | North America |
Key Topics Covered:
1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. North America Beta-Glucan Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Source
6.2 By Product
6.3 By Application
6.4 By Countries
7. Source
7.1 Cereal
7.2 Mushroom
7.3 Yeast
7.4 Seaweed
8. Product
8.1 Soluble
8.2 Insoluble
9. Application
9.1 Food & Beverages
9.2 Pharmaceuticals
9.3 Cosmetics & Personal Care
9.4 Animal Feed
9.5 Others
10. Countries
10.1 United States
10.2 Canada
10.3 Mexico
10.4 Rest of North America
11. Porter’s Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Key Players Analysis
For more information about this report visit https://www.researchandmarkets.com/r/caphxp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- North American Beta-Glucan Market
